MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 164 filers reported holding MIRATI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,400,260 | +253.0% | 5,748,399 | +466.0% | 8.45% | +303.5% |
| Q3 2022 | $70,928,000 | +72.3% | 1,015,572 | +102.9% | 2.09% | +62.5% |
| Q1 2022 | $41,161,000 | -49.9% | 500,622 | +7.8% | 1.29% | -54.9% |
| Q3 2021 | $82,139,000 | +9.5% | 464,298 | 0.0% | 2.86% | +2.0% |
| Q2 2021 | $74,998,000 | -5.7% | 464,298 | 0.0% | 2.80% | -20.5% |
| Q1 2021 | $79,534,000 | -22.0% | 464,298 | 0.0% | 3.53% | -35.6% |
| Q4 2020 | $101,978,000 | +32.3% | 464,298 | 0.0% | 5.48% | -0.3% |
| Q3 2020 | $77,097,000 | +88.7% | 464,298 | +29.7% | 5.50% | +82.2% |
| Q2 2020 | $40,856,000 | +48.5% | 357,849 | 0.0% | 3.02% | +5.0% |
| Q1 2020 | $27,508,000 | +228.4% | 357,849 | +450.5% | 2.87% | +280.7% |
| Q4 2019 | $8,376,000 | +143.1% | 65,000 | +47.0% | 0.76% | +73.6% |
| Q3 2019 | $3,445,000 | -94.4% | 44,221 | -92.6% | 0.44% | -93.0% |
| Q2 2019 | $61,564,000 | -16.0% | 597,711 | -40.2% | 6.22% | -7.9% |
| Q1 2019 | $73,300,000 | +167.0% | 1,000,000 | +54.5% | 6.76% | +146.0% |
| Q4 2018 | $27,453,000 | +1357.2% | 647,169 | +526.9% | 2.75% | +1195.8% |
| Q4 2017 | $1,884,000 | – | 103,240 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |